We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$2.72B
1-Year Est. Return
121.58%
This Fund
S&P 500
This Quarter
Est. Return
-11.58%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.26B
AUM Growth
-$582M
(-20%)
Cap. Flow
-$263M
Cap. Flow
% of AUM
-11.62%
Top 10 Holdings %
Top 10 Hldgs %
52.07%
Holding
149
New
14
Increased
25
Reduced
74
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$66.4M |
| 2 |
LNW
Light & Wonder
LNW
|
+$63.6M |
| 3 |
Peloton Interactive
PTON
|
+$14M |
| 4 |
FTVI
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
|
+$9.79M |
| 5 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
+$9.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GDEN
Golden Entertainment
GDEN
|
+$19.5M |
| 2 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
+$16.6M |
| 3 |
STR
Sitio Royalties
STR
|
+$11.6M |
| 4 |
Akebia Therapeutics
AKBA
|
+$10.5M |
| 5 |
FTVIU
FinTech Acquisition Corp. VI Units
FTVIU
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.38% |
| 2 | Consumer Discretionary | 13.81% |
| 3 | Financials | 5.18% |
| 4 | Industrials | 5.14% |
| 5 | Technology | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FAZE
76
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $2.99M | 0.13% |
301,786
-47,863
| -14% | -$475K |
|
77
Neuronetics
STIM
$212M
| $2.67M | 0.12% |
+880,155
| New | +$2.97M |
|
|
IMV
78
DELISTED
IMV Inc. Common Shares
IMV
| $2.63M | 0.12% |
186,649
-18,872
| -9% | -$239K |
|
79
Elicio Therapeutics
ELTX
$79.8M
| $2.49M | 0.11% |
117,316
-9,387
| -7% | -$212K |
|
|
BACK
80
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $2.31M | 0.1% |
74,704
-5,032
| -6% | -$171K |
|
81
CALL
Keros Therapeutics
KROS
$210M
| $2.28M | 0.1% |
41,900
+2,200
| +6% | +$113K |
|
|
ACER
82
DELISTED
Acer Therapeutics Inc
ACER
| $2.26M | 0.1% |
777,820
-123,470
| -14% | -$298K |
|
|
ZVO
83
DELISTED
Zovio Inc. Common Stock
ZVO
| $2.14M | 0.09% |
2,613,763
-367,004
| -12% | -$413K |
|
84
Hyperfine
HYPR
$99.7M
| $2.11M | 0.09% |
596,480
-122,157
| -17% | -$505K |
|
|
SLNO
85
DELISTED
Soleno Therapeutics
SLNO
| $2.1M | 0.09% |
629,101
-21,908
| -3% | -$113K |
|
|
IDW
86
DELISTED
IDW Media Holdings
IDW
| $2.05M | 0.09% |
1,118,406
-110,837
| -9% | -$224K |
|
|
PAYA
87
CALL
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $1.76M | 0.08% |
+300,000
| New | +$1.81M |
|
|
FFAI
88
Faraday Future Intelligent Electric
FFAI
$10.6M
| – | – |
0
| – | – |
|
|
IMTXW
89
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.74M | 0.08% |
1,035,613
-35,853
| -3% | -$82.5K |
|
90
Payoneer
PAYO
$2.4B
| $1.72M | 0.08% |
385,366
-13,318
| -3% | -$67.3K |
|
91
Wave Life Sciences
WVE
$1.02B
| $1.64M | 0.07% |
819,101
-87,993
| -10% | -$216K |
|
|
FVAM
92
DELISTED
5:01 Acquisition Corp
FVAM
| $1.6M | 0.07% |
162,430
-19,497
| -11% | -$192K |
|
93
Gyre Therapeutics
GYRE
$701M
| $1.6M | 0.07% |
322,772
-45,449
| -12% | -$225K |
|
|
LVTX
94
DELISTED
LAVA Therapeutics
LVTX
| $1.47M | 0.07% |
334,164
-26,644
| -7% | -$135K |
|
|
MILE
95
DELISTED
Metromile, Inc. Common Stock
MILE
| $1.38M | 0.06% |
1,043,514
-76,098
| -7% | -$110K |
|
96
Alector
ALEC
$232M
| $1.35M | 0.06% |
+94,779
| New | +$1.5M |
|
97
Exagen
XGN
$168M
| $1.28M | 0.06% |
159,253
-27,683
| -15% | -$239K |
|
98
IN8bio
INAB
$10.3M
| $1.23M | 0.05% |
11,758
-681
| -5% | -$76.2K |
|
99
Lucid Diagnostics
LUCD
$186M
| $1.06M | 0.05% |
315,414
-119,641
| -28% | -$437K |
|
|
WEJO
100
DELISTED
Wejo Group Limited Common Shares
WEJO
| $857K | 0.04% |
+214,966
| New | +$931K |
|
Similar funds
TAM
XL
PA
BCM
SCM
HCM
GC
LP
Nantahala Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Nantahala Capital Management held 149 positions worth $2.26B, down 20% from $2.84B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Nantahala Capital Management withdrew a net $263M in Q1 2022, closing 27 positions and reducing 74 holdings. Its most notable exit was SANTANDER CONSUMER USA HOLDINGS INC, an estimated $16.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Nantahala Capital Management opened a new position in FinTech Acquisition Corp. VI Class A Common Stock worth $9.82M.
- Nantahala Capital Management's largest Q1 2022 buy was FinTech Acquisition Corp. VI Class A Common Stock: 999,992 shares worth $9.82M.
- Nantahala Capital Management added most to iShares Russell 2000 ETF in Q1 2022, an estimated $66.4M increase.
- Nantahala Capital Management's biggest Q1 2022 reduction was Golden Entertainment, cutting an estimated $19.5M.
- Nantahala Capital Management fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q1 2022, selling an estimated $16.6M.
- Nantahala Capital Management's ten largest holdings make up 52% of its $2.26B portfolio in Q1 2022.
- Nantahala Capital Management opened 14 new positions and closed 27 in Q1 2022.
- Nantahala Capital Management's portfolio value fell 20% quarter-over-quarter to $2.26B.
Based on Nantahala Capital Management's 13F filing for Q1 2022, filed 13 May 2022.